Mutation Found in Pre-Treatment Tumor Causes Drug Resistance

A new study improves the understanding of a mutation that causes resistance to targeted melanoma therapies. The mutation was determined to be present in the tumor pre-treatment and was not an acquired resistance variation that developed after treatment, as previously understood. The study findings were published in Cancer DiscoveryRead more.

Author: Dr. Baek

- Scientist (Microbiology, Synthetic Biology, Molecular Biology). - Founder / CEO of the biotech company Peption LLC. - Passionate about biotechnological innovations to address important global health issues.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s